EUVIMEDEUVIMED entdecken
Crossref

Spinigerin-Mediated Inhibition of Multidrug-Resistant Klebsiella pneumoniae: A Study on Peptide Antibiotic Efficacy

I. H. Iheukwumere, C. M. Iheukwumere, V. E. Ike, B. C. Unaeze, P. A. Nnagbo, C. A. Mere

Health Science Research International · 07.04.2026 · 3 (1) · 62-71

DOI: 10.54117/hsri.v3i1.58 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Science Research International, online erschienen am 07.04.2026. Verfasst von I. H. Iheukwumere und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae is a significant pathogen responsible for various infections, and its increasing antibiotic resistance poses a major public health concern. This study aimed to isolate and characterize K. pneumoniae from clinical samples and evaluate the antibacterial activity of spinigerin, an antimicrobial peptide, against multidrug-resistant (MDR) K. pneumoniae isolates. K. pneumoniae isolates were characterized using cultural, morphological, biochemical, and molecular tests. Antibiotic resistance profiles were determined using standard methods. The antibacterial activity of spinigerin was assessed using minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) assays. Three K. pneumoniae strains A27782, K60365 and DD02425 (KPA2, KPK6, and KPDD) were identified, exhibiting high and variable levels of multidrug resistance. Spinigerin showed potent, strain-dependent antibacterial activity against the MDR isolates, with MIC and MBC values ranging from 0.00781 to 0.25000 mg/mL and 0.06250 to 0.50000 mg/mL, respectively. Statistical analysis revealed significant differences in susceptibility patterns among the isolates (p < 0.05). Spinigerin exhibits promising antibacterial activity against MDR K. pneumoniae isolates, suggesting its potential as an alternative therapeutic agent against antibiotic-resistant infections. This study highlights the potential of spinigerin as a novel antibacterial agent against MDR K. pneumoniae, providing a new avenue for combating antibiotic resistance.

Zitieren

APA

Iheukwumere, I. H., Iheukwumere, C. M., Ike, V. E., Unaeze, B. C., Nnagbo, P. A., & Mere, C. A. (2026). Spinigerin-Mediated Inhibition of Multidrug-Resistant Klebsiella pneumoniae: A Study on Peptide Antibiotic Efficacy. Health Science Research International, 3(1), 62-71. https://doi.org/10.54117/hsri.v3i1.58

Vancouver

Iheukwumere IH, Iheukwumere CM, Ike VE, Unaeze BC, Nnagbo PA, Mere CA. Spinigerin-Mediated Inhibition of Multidrug-Resistant Klebsiella pneumoniae: A Study on Peptide Antibiotic Efficacy. Health Science Research International. 2026;3(1):62-71. doi:10.54117/hsri.v3i1.58

BibTeX
@article{Iheukwumere2026,
  author = {Iheukwumere, I. H. and Iheukwumere, C. M. and Ike, V. E. and Unaeze, B. C. and Nnagbo, P. A. and Mere, C. A.},
  title = {Spinigerin-Mediated Inhibition of Multidrug-Resistant Klebsiella pneumoniae: A Study on Peptide Antibiotic Efficacy},
  journal = {Health Science Research International},
  year = {2026},
  volume = {3},
  number = {1},
  pages = {62--71},
  doi = {10.54117/hsri.v3i1.58}
}
Kostenlos starten →